Spark Therapeutics Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Spark Therapeutics Inc (ONCE) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Spark Therapeutics Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 70M vs -M combined for its competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+28.5% annualized vs trailing 12 months).
- Peer revenue share: Spark Therapeutics Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
ONCE Sales vs. its Competitors, Q2 2019
Spark Therapeutics Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
API endpoints for this dataset
For context: the Biotechnology & Pharmaceuticals industry grew revenue 21.4% year over year, combined, vs 109.7% for Spark Therapeutics Inc. Spark Therapeutics Inc's share of combined industry revenue moved from 0.03% to 0.05%, a gain of 0.02 percentage points.
Spark Therapeutics Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Spark Therapeutics Inc | No | Yes | Yes | Yes |
| High-Confidence Competitors (2) | - |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
ONCE Stock Performance relative to its Competitors
ONCE Stock Performance relative to High-Confidence Competitors
Spark Therapeutics Inc's Competitors Named by the Company
Competitive relationships identified from Spark Therapeutics Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Voyager Therapeutics Inc | Company report | 85% |
| 4d Molecular Therapeutics Inc | Company report | 85% |
Company report basis, confidence, active dates and source counts for Spark Therapeutics Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
